Inventor
DEBERNARDIS JOHN F
US26 patents
⚠️ This page may combine multiple inventors who share the name “DEBERNARDIS JOHN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
25 patentsUS4665095AMay 12, 1987
Use of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestion
ABBOTT LAB50 citations96
US4634705AJan 6, 1987
Adrenergic amidines
ABBOTT LAB78 citations96
US5326776AJul 5, 1994
Angiotensin II receptor antagonists
ABBOTT LAB92 citations95
US5250548AOct 5, 1993
Angiotensin II receptor antagonists
ABBOTT LAB57 citations95
US5244888ASep 14, 1993
5-HT selective agents
ABBOTT LAB26 citations92
US5049564ASep 17, 1991
5-HT selective agents
ABBOTT LAB42 citations92
US4500543AFeb 19, 1985
Substituted 1-aminomethyl-phthalans
ABBOTT LAB27 citations92
US5288749AFeb 22, 1994
Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
ABBOTT LAB26 citations91
US4963568AOct 16, 1990
Dopamine agonists
ABBOTT LAB52 citations90
US4618683AOct 21, 1986
Tetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedatives
ABBOTT LAB24 citations81
US4963563AOct 16, 1990
6-substituted-1,2,3,4-tetrahydroisoquinolines
ABBOTT LAB15 citations74
US4622405ANov 11, 1986
1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
ABBOTT LAB16 citations74
US4440769AApr 3, 1984
2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
ABBOTT LAB8 citations74
US5389638AFeb 14, 1995
Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
ABBOTT LAB7 citations73
US5185364AFeb 9, 1993
Aminomethyl-chroman and -thiochroman compounds
ABBOTT LAB10 citations73
US5140040AAug 18, 1992
1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
ABBOTT LAB13 citations73
US5140039AAug 18, 1992
Aminomethyl-thiochroman compounds
ABBOTT LAB7 citations73
US5128362AJul 7, 1992
1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
ABBOTT LAB12 citations73
US4505932AMar 19, 1985
Method of producing α2 -adrenergic receptor agonist activity
ABBOTT LAB8 citations73
US4473586ASep 25, 1984
Aminoalkyl dihydronaphthalenes
ABBOTT LAB13 citations73
US5180733AJan 19, 1993
Biogenic amine uptake inhibitors
ABBOTT LAB4 citations62
US5086074AFeb 4, 1992
1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
ABBOTT LAB3 citations62
US5248677ASep 28, 1993
Biogentic amine uptake inhibitors
ABBOTT LAB1 citations52
US5089519AFeb 18, 1992
Aminomethyl-chroman compounds
ABBOTT LAB0 citations52
US4269858AMay 26, 1981
Antihypertensive method
ABBOTT LAB0 citations50